These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22952422)

  • 1. Stromal cell-derived factor 1α mediates resistance to mTOR-directed therapy in pancreatic cancer.
    Weekes CD; Song D; Arcaroli J; Wilson LA; Rubio-Viqueira B; Cusatis G; Garrett-Mayer E; Messersmith WA; Winn RA; Hidalgo M
    Neoplasia; 2012 Aug; 14(8):690-701. PubMed ID: 22952422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase II study of temsirolimus and erlotinib in patients with recurrent and/or metastatic, platinum-refractory head and neck squamous cell carcinoma.
    Bauman JE; Arias-Pulido H; Lee SJ; Fekrazad MH; Ozawa H; Fertig E; Howard J; Bishop J; Wang H; Olson GT; Spafford MJ; Jones DV; Chung CH
    Oral Oncol; 2013 May; 49(5):461-7. PubMed ID: 23384718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of Chanling Gao on the proliferation and liver metastasis of transplanted colorectal cancer in nude mice.
    Yang B; Pan CS; Li Q; Yang Z; Long FX; Fan JY; Wang CS; Han JY; Tang DX
    PLoS One; 2019; 14(2):e0201504. PubMed ID: 30789971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCR4-modified CAR-T cells suppresses MDSCs recruitment via STAT3/NF-κB/SDF-1α axis to enhance efficacy against pancreatic cancer.
    Sun R; Sun Y; Wu C; Liu Y; Zhou M; Dong Y; Du G; Luo H; Shi B; Jiang H; Li Z
    Mol Ther; 2023 Nov; 31(11):3193-3209. PubMed ID: 37735875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromal-derived factor-1α/CXCL12-CXCR4 chemotactic pathway promotes perineural invasion in pancreatic cancer.
    Xu Q; Wang Z; Chen X; Duan W; Lei J; Zong L; Li X; Sheng L; Ma J; Han L; Li W; Zhang L; Guo K; Ma Z; Wu Z; Wu E; Ma Q
    Oncotarget; 2015 Mar; 6(7):4717-32. PubMed ID: 25605248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomaterial-enabled delivery of SDF-1α at the ventral side of breast cancer cells reveals a crosstalk between cell receptors to promote the invasive phenotype.
    Liu XQ; Fourel L; Dalonneau F; Sadir R; Leal S; Lortat-Jacob H; Weidenhaupt M; Albiges-Rizo C; Picart C
    Biomaterials; 2017 May; 127():61-74. PubMed ID: 28279922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SDF-1/CXCL12 induces directional cell migration and spontaneous metastasis via a CXCR4/Gαi/mTORC1 axis.
    Dillenburg-Pilla P; Patel V; Mikelis CM; Zárate-Bladés CR; Doçi CL; Amornphimoltham P; Wang Z; Martin D; Leelahavanichkul K; Dorsam RT; Masedunskas A; Weigert R; Molinolo AA; Gutkind JS
    FASEB J; 2015 Mar; 29(3):1056-68. PubMed ID: 25466898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nanobody targeting PD-L1 and CXCR4 counteracts pancreatic stellate cell-mediated tumour progression by disrupting tumour microenvironment.
    Li Y; Zheng Y; Xu S; Hu H; Peng L; Zhu J; Wu M
    Int Immunopharmacol; 2024 May; 132():111944. PubMed ID: 38581990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MNK kinases facilitate c-myc IRES activity in rapamycin-treated multiple myeloma cells.
    Shi Y; Frost P; Hoang B; Yang Y; Fukunaga R; Gera J; Lichtenstein A
    Oncogene; 2013 Jan; 32(2):190-7. PubMed ID: 22370634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of SDF-1α/CXCR4 signaling pathway in clinicopathological features and prognosis of patients with nasopharyngeal carcinoma.
    Li YL; Li YF; Li HF; Lv HQ; Sun DZ
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28559386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of PP2A and Inhibition of mTOR Synergistically Reduce MYC Signaling and Decrease Tumor Growth in Pancreatic Ductal Adenocarcinoma.
    Allen-Petersen BL; Risom T; Feng Z; Wang Z; Jenny ZP; Thoma MC; Pelz KR; Morton JP; Sansom OJ; Lopez CD; Sheppard B; Christensen DJ; Ohlmeyer M; Narla G; Sears RC
    Cancer Res; 2019 Jan; 79(1):209-219. PubMed ID: 30389701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined treatment with crizotinib and temsirolimus is an effective strategy in mantle cell lymphoma and can overcome acquired resistance to temsirolimus.
    Moosburner M; Alibegovic L; Hasselmann K; Gaiderov A; Hildebrand J; Philippou-Massier J; Blum H; Fischer L; Dreyling M; Silkenstedt E
    Hematol Oncol; 2023 Dec; 41(5):858-868. PubMed ID: 37300279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of mammalian target of rapamycin signaling by CCI-779 (temsirolimus) induces growth inhibition and cell cycle arrest in Cashmere goat fetal fibroblasts (Capra hircus).
    Wang Z; Liu T; Chen Y; Zhang X; Liu M; Fu H; Liu D
    DNA Cell Biol; 2012 Jun; 31(6):1095-9. PubMed ID: 22320865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triazolothiadiazine derivative positively modulates CXCR4 signaling and improves diabetic wound healing.
    Peddibhotla S; Caples K; Mehta A; Chen QY; Hu J; Idlett-Ali S; Zhang L; Zgheib C; Xu J; Liechty KW; Malany S
    Biochem Pharmacol; 2023 Oct; 216():115764. PubMed ID: 37634595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mTOR Signaling Pathway and mTOR Inhibitors in Cancer: Next-generation Inhibitors and Approaches.
    Ihlamur M; Akgul B; Zengin Y; Korkut ŞV; Kelleci K; Abamor EŞ
    Curr Mol Med; 2024; 24(4):478-494. PubMed ID: 37165594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EPI-X4, a CXCR4 antagonist inhibits tumor growth in pancreatic cancer and lymphoma models.
    Sagini MN; Zepp M; Eyol E; Ali DM; Gromova S; Dahlmann M; Behrens D; Groeschel C; Tischmeier L; Hoffmann J; Berger MR; Forssmann WG
    Peptides; 2024 May; 175():171111. PubMed ID: 38036098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Cytoprotective and Cytotoxic Functions of Autophagy in Response to mTOR Inhibitors.
    Elshazly AM; Elzahed AA; Gewirtz DA
    Front Biosci (Landmark Ed); 2024 Jun; 29(6):231. PubMed ID: 38940039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCR4 blockade induces atherosclerosis by affecting neutrophil function.
    Bot I; Daissormont IT; Zernecke A; van Puijvelde GH; Kramp B; de Jager SC; Sluimer JC; Manca M; Hérias V; Westra MM; Bot M; van Santbrink PJ; van Berkel TJ; Su L; Skjelland M; Gullestad L; Kuiper J; Halvorsen B; Aukrust P; Koenen RR; Weber C; Biessen EA
    J Mol Cell Cardiol; 2014 Sep; 74():44-52. PubMed ID: 24816217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatiotemporal presentation of exogenous SDF-1 with PLGA nanoparticles modulates SDF-1/CXCR4 signaling axis in the rodent cortex.
    Dutta D; Hickey K; Salifu M; Fauer C; Willingham C; Stabenfeldt SE
    Biomater Sci; 2017 Jul; 5(8):1640-1651. PubMed ID: 28703822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-Based Disparities in Leukocyte Migration and Activation in Response to Inhalation Lung Injury: Role of SDF-1/CXCR4 Signaling.
    Chatterjee T; Lewis TL; Arora I; Gryshyna AE; Underwood L; Masjoan Juncos JX; Aggarwal S
    Cells; 2023 Jun; 12(13):. PubMed ID: 37443753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.